Correlation Between AgeX Therapeutics and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AgeX Therapeutics and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AgeX Therapeutics and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AgeX Therapeutics and Replimune Group, you can compare the effects of market volatilities on AgeX Therapeutics and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AgeX Therapeutics with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of AgeX Therapeutics and Replimune.

Diversification Opportunities for AgeX Therapeutics and Replimune

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between AgeX and Replimune is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding AgeX Therapeutics and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and AgeX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AgeX Therapeutics are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of AgeX Therapeutics i.e., AgeX Therapeutics and Replimune go up and down completely randomly.

Pair Corralation between AgeX Therapeutics and Replimune

Considering the 90-day investment horizon AgeX Therapeutics is expected to generate 1.32 times more return on investment than Replimune. However, AgeX Therapeutics is 1.32 times more volatile than Replimune Group. It trades about 0.1 of its potential returns per unit of risk. Replimune Group is currently generating about 0.02 per unit of risk. If you would invest  58.00  in AgeX Therapeutics on August 29, 2024 and sell it today you would earn a total of  16.00  from holding AgeX Therapeutics or generate 27.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy13.74%
ValuesDaily Returns

AgeX Therapeutics  vs.  Replimune Group

 Performance 
       Timeline  
AgeX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AgeX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, AgeX Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Replimune Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

AgeX Therapeutics and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AgeX Therapeutics and Replimune

The main advantage of trading using opposite AgeX Therapeutics and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AgeX Therapeutics position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind AgeX Therapeutics and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas